Incidence and prevalence of organ toxicities in patients suffering from clear cell renal carcinoma treated with sunitinib and its impact on survival: a reference cancer center experience
{{output}}
Introduction: Tyrosine kinase inhibitors (TKIs) are the standard treatment options for advanced clear cell renal cell carcinoma (ccRCC), but their toxicities can hinder optimal dosing, affecting clinical outcomes. ... ...
